Patents-Review.com
ClassID:

114556 ⎘

C12Y116/03001 - CPC Classification

Classification description:

Oxidoreductases oxidizing metal ions (1.16) with oxygen as acceptor (1.16.3) Ferroxidase (1.16.3.1), i.e. ceruloplasmin

Recent Application in this class:
#1
20250369031
2025-12-04

METHODS OF DETERMINING CERULOPLASMIN ACTIVITY AND APPLICATIONS THEREOF

 #2
20250163469
2025-05-22

ADENO-ASSOCIATED VIRUS VARIANT CAPSIDS AND METHODS OF USE THEREOF

 #3
20250109408
2025-04-03

METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY DUE TO ENERGY FAILURE

 #4
20250109407
2025-04-03

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY DUE TO ENERGY FAILURE

 #5
20250018062
2025-01-16

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEINS ASSOCIATED WITH HUMAN DISEASE

 #6
20230279435
2023-09-07

Adeno-associated virus variant capsids and methods of use thereof

 #7
20230181688
2023-06-15

METHODS FOR TREATING PLASMA PROTEIN IMBALANCES OR DEPLETION

 #8
20220251145
2022-08-11

Adeno-associated virus variant capsids and methods of use thereof

 #9
20220090128
2022-03-24

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY DUE TO ENERGY FAILURE

 #10
20210380643
2021-12-09

Adeno-associated virus variant capsids and methods of use thereof

 #11
20210340565
2021-11-04

METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY DUE TO ENERGY FAILURE

 #12
20200308239
2020-10-01

GENETICALLY ENCODED FLUORESCENT-IRON FERRITIN NANOPARTICLE PROBES FOR DETECTING AN INTRACELLULAR TARGET BY FLUORESCENT AND ELECTRON MICROSCOPY

 #13
20200157564
2020-05-21

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY DUE TO ENERGY FAILURE

 #14
20200155706
2020-05-21

Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins

 #15
20190314527
2019-10-17

In vivo production of proteins

 #16
20180353543
2018-12-13

Compositions derived from Cohn fraction paste and use thereof

 #17
20180334687
2018-11-22

METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY DUE TO ENERGY FAILURE

 #18
20180311381
2018-11-01

Modified Polynucleotides for the production of biologics and proteins associated with human disease

 #19
20180030452
2018-02-01

TARGETING OLIGONUCLEOTIDES AND USES THEREOF TO MODULATE GENE EXPRESSION

 #20
20170368200
2017-12-28

Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins

 #21
20170348436
2017-12-07

In vivo production of proteins

 #22
20170266266
2017-09-21

Functions of 55 Newfound Proteins and Their Medicinal Application in the Treatment and Prevention of Disease

 #23
20160075733
2016-03-17

Modified polynucleotides for the production of biologics and proteins associated with human disease

 #24
20160060605
2016-03-03

Frataxin mutants

 #25
20150313969
2015-11-05

Methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy due to Friedreich ataxia